期刊文献+

肠胃清对人结直肠癌耐长春新碱细胞株HCT8/V的逆转作用 被引量:15

Reversal of multidrug resistance by "Changweiqing" on vincristine-resistant human colorectal cancer cell line HCT8/V
在线阅读 下载PDF
导出
摘要 目的:探讨中药复方肠胃清对人结直肠癌耐长春新碱(vincristine,VCR)细胞株HCT8/V多药耐药的逆转作用。方法:采用细胞增殖抑制实验MTT法观察肠胃清药物血清对HCT8/V细胞株多药耐药性的逆转作用,采用高效液相色谱方法检测肠胃清药物血清作用后的耐药细胞内VCR药物浓度的改变。结果:本实验所采用的人结直肠癌耐VCR细胞株HCT8/V的耐VCR倍数为20.24倍,且对5-氟尿嘧啶、顺铂、羟基喜树碱和丝裂霉素这4种结构和作用机制各异的化疗药物有交叉耐药现象,具有多药耐药性,肠胃清能够逆转HCT8/V的耐药现象。高效液相色谱法结果显示,肠胃清药物血清处理HCT8/V48h后,细胞内的VCR浓度明显增高,且呈剂量依赖性。结论:肠胃清药物血清可提高HCT8/V细胞内化疗药物的浓度,有效逆转耐药细胞的多药耐药现象。 Objective : To investigate the reverse effect of traditional Chinese medicine compound Changweiqing (CWQ) mixture on the vincristine ( V)-resistant human colorectal cancer cell line HCT-8/V. Methods: The reverse effect of serum containing CWQ (SC) on multidrug resistance (MDR) of HCT-8 and HCT-8/V cells was evaluated by MTT assay. Intracellular vincristine concentration in HCT-8/V cells was analyzed by high performance liquid chromatography(HPLC) after treatment with CDS. Results:The vincristine (V) -resistant culurectal cancer cell line HCT-8/V, a MDR cell line, exhibited 20.24-fold resistance to vlncristine and cross-resistance to the four chemotherapeutic drugs, 5-FU, DDP, HCPF and MMC, which had different structures and action mechanisms. It indicated that HCT-8/V had characteristics of muhidrug resistance. SC could reverse drug resistance of HCT-8/V cell line. The data of HPLC showed that the intracellular concentration of vincristine in the HCTS/V ceils was increased by 48-h treatment with SC. The effect was dose-dependent. Conclusion:CWQ elevates the intracellular concentration of vincristine and effectively reverses mulitidrug resistance of HCT-8/V cell line.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第9期755-757,762,共4页 Tumor
基金 国家自然科学基金资助项目(编号:30672683) 上海市教委资助项目(编号:05CZ16)
关键词 结直肠肿瘤 抗肿瘤药(中药) 肿瘤细胞 培养的 抗药性 多药 血清 Colorectal neoplasms Antineoplastic drugs(TCD) Tumor cells,cultured Drug resistance,multiple Serum
  • 相关文献

参考文献5

二级参考文献94

共引文献103

同被引文献257

引证文献15

二级引证文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部